year
increas
number
peopl
travel
kingdom
saudi
arabia
ksa
hajj
umrah
pilgrimag
attract
around
million
pilgrim
annual
countri
two
million
pilgrim
outsid
saudi
arabia
particip
hajj
pilgrimag
year
pilgrim
marseil
franc
particip
hajj
event
present
major
challeng
public
health
includ
interhuman
transmiss
infecti
diseas
notabl
respiratori
tract
infect
rti
due
crowd
condit
experienc
pilgrim
recent
studi
morbid
mortal
among
indian
hajj
pilgrim
infecti
diseas
repres
outpati
diagnos
rti
gastroenter
common
french
pilgrim
present
rti
symptom
hajj
recent
literatur
review
suggest
etiolog
rti
hajj
complex
sever
studi
show
signific
acquisit
respiratori
pathogen
pilgrim
follow
particip
hajj
symptomat
asymptomat
individu
systemat
review
studi
altawfiq
et
al
show
human
rhinoviru
hrv
influenza
virus
common
viral
respiratori
pathogen
isol
ill
hajj
pilgrim
addit
human
nonmer
coronavirus
hcov
also
common
caus
rti
event
hand
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
shown
commonli
acquir
respiratori
bacteria
hajj
rti
caus
antagonist
synergist
interact
upper
respiratori
tract
virus
predomin
bacteri
pathogen
pathogen
usual
studi
individu
although
natur
environ
often
compet
coexist
multipl
microbi
speci
similarli
diagnosi
infect
often
proce
via
approach
assum
singl
agent
etiolog
nevertheless
complex
interact
occur
differ
infecti
microorgan
live
ecolog
nich
mix
infect
frequent
better
understand
polymicrobi
interact
nasopharynx
among
hajj
pilgrim
import
mani
reason
carriag
one
pathogen
common
among
hajj
pilgrim
whether
present
respiratori
symptom
colon
initi
step
diseas
process
nasopharyng
colon
like
reservoir
respiratori
pathogen
result
interhuman
transmiss
pilgrim
close
contact
experienc
hajj
ritual
furthermor
antibiot
use
vaccin
target
specif
pathogen
speci
may
alter
polymicrobi
interact
nasopharynx
unanticip
consequ
knowledg
dynam
interact
main
respiratori
pathogen
acquir
hajj
pilgrimag
specif
investig
date
risk
factor
possibl
lower
respiratori
tract
infect
lrti
symptom
hajj
studi
conduct
studi
among
french
pilgrim
hajj
describ
dynam
acquisit
respiratori
pathogen
potenti
interact
addit
investig
risk
factor
possibl
lrti
symptom
pilgrim
travel
mecca
saudi
arabia
hajj
marseil
franc
recruit
privat
special
travel
agenc
potenti
adult
particip
invit
particip
studi
includ
followedup
two
bilingu
arab
french
medic
doctor
travel
group
particip
depart
ksa
date
hous
accommod
stay
perform
ritual
togeth
upon
inclus
depart
franc
pilgrim
interview
use
standard
prehajj
questionnair
collect
inform
demograph
characterist
medic
histori
immun
statu
pilgrim
consid
immun
influenza
vaccin
within
past
year
day
date
travel
pilgrim
consid
immun
invas
pneumococc
diseas
ipd
vaccin
conjug
pneumococc
vaccin
past
five
year
posthajj
questionnair
complet
two
day
pilgrim
return
franc
clinic
data
antibiot
intak
inform
complianc
face
mask
use
well
hand
wash
use
hand
gel
disinfect
dispos
handkerchief
collect
evalu
dynam
interact
respiratori
pathogen
hajj
pilgrim
underw
four
success
systemat
nasopharyng
swab
differ
time
pretravel
five
six
day
post
arriv
day
post
arriv
prior
leav
ksa
posthajj
hajj
ritual
took
place
august
ill
ili
defin
presenc
cough
sore
throat
subject
fever
possibl
lrti
defin
presenc
product
cough
without
nasal
throat
symptom
febril
product
cough
dyspnea
febril
dyspnea
base
classif
underweight
defin
bodi
mass
index
bmi
normal
correspond
bmi
overweight
correspond
bmi
obes
refer
bmi
nasopharyng
swab
obtain
pilgrim
transfer
medium
store
process
sampl
done
doctor
accompani
group
standard
way
cm
nostril
turn
post
wall
pharynx
streak
rna
dna
extract
sampl
use
advanc
xl
qiagen
hilden
german
viru
mini
kit
qiagen
accord
manufactur
recommend
quantit
realtim
pcr
perform
use
thermal
cycl
biorad
hercul
ca
usa
onestep
simplex
realtim
quantit
amplif
perform
use
multiplex
rna
viru
master
kit
roch
diagnost
franc
influenza
influenza
b
hrv
intern
control
phage
hcov
detect
onestep
duplex
quantit
amplif
hcov
hpivr
gene
kit
ref
marci
l
etoil
franc
accord
manufactur
recommend
realtim
pcr
amplif
carri
use
probe
master
kit
roch
diagnost
franc
accord
manufactur
recommend
shd
gene
h
influenza
phoe
gene
klebsiella
pneumonia
nuca
gene
aureu
lyta
cdc
gene
pneumonia
copb
gene
moraxella
catarrhali
amplifi
intern
dna
extract
control
tiss
previous
describ
human
adenoviru
human
metapneumoviru
respiratori
syncyti
viru
bordetella
pertussi
mycoplasma
pneumonia
test
low
proport
return
french
pilgrim
intern
pilgrim
found
posit
pathogen
previou
work
neg
control
pcr
mix
posit
control
dna
bacteri
strain
rna
viral
strain
includ
run
posit
result
bacteria
viru
amplif
defin
cycl
threshold
ct
valu
threshold
valu
use
experiment
run
calcul
rfu
cut
valu
recommend
cfx
manag
softwar
version
biorad
order
verifi
posit
case
result
consid
posit
cycl
threshold
valu
realtim
pcr
greater
cut
valu
pilgrim
consid
posit
respiratori
pathogen
hajj
posit
day
andor
day
sampl
stata
softwar
version
copyright
statacorp
llc
http
wwwstatacom
use
statist
analysi
main
outcom
interest
relationship
respiratori
pathogen
among
pilgrim
hajj
evalu
carriag
hrv
hcov
aureu
pneumonia
h
influenza
k
pneumonia
catarrhali
use
logist
mix
model
pilgrim
provid
four
success
sampl
use
repeat
measur
design
take
account
variabl
seri
sampl
pilgrim
evalu
effect
covari
respiratori
pathogen
carriag
model
carriag
hrv
hcov
aureu
pneumonia
h
influenza
k
pneumonia
catarrhali
separ
separ
model
outcom
carriag
influenza
b
virus
low
preval
virus
variabl
preval
consid
statist
analysi
unadjust
associ
respiratori
pathogen
carriag
multipl
factor
sociodemograph
characterist
gender
year
chronic
respiratori
diseas
bmi
classif
smoke
statu
individu
prevent
measur
vaccin
influenza
vaccin
ipd
use
face
mask
hand
wash
disinfect
gel
dispos
handkerchief
antibiot
intak
day
sampl
respiratori
viru
bacteria
dual
carriag
analys
univari
analysi
variabl
p
valu
univari
analysi
includ
multivari
analysi
mix
model
subject
random
effect
use
estim
relationship
respiratori
pathogen
take
account
repeat
measur
pathogen
carriag
subject
regard
risk
factor
lrti
outcom
possibl
lrti
symptom
report
hajj
independ
factor
sociodemograph
characterist
gender
year
chronic
respiratori
diseas
smoke
statu
bmi
classif
vaccin
influenza
vaccin
ipd
respiratori
viru
bacteria
dual
carriag
hajj
unadjust
associ
multipl
factor
possibl
lrti
symptom
examin
use
univari
analysi
variabl
p
valu
univari
analysi
includ
multivari
analysi
logist
regress
model
use
estim
factor
adjust
odd
ratio
regard
possibl
lrti
result
present
odd
ratio
confid
interv
ci
result
p
valu
consid
statist
signific
protocol
approv
aixmarseil
univers
institut
review
board
juli
refer
studi
perform
accord
good
clinic
practic
recommend
declar
helsinki
amend
particip
provid
written
inform
consent
studi
includ
pilgrim
sex
ratio
popul
median
age
year
pilgrim
age
year
pilgrim
born
north
africa
subsaharan
africa
high
preval
overweight
obes
diabet
mellitu
hypertens
particip
report
suffer
chronic
respiratori
diseas
line
french
recommend
pilgrim
indic
vaccin
ipd
tabl
total
pilgrim
report
vaccin
influenza
past
year
pilgrim
indic
ipd
vaccin
pneumococc
diseas
past
five
year
regard
nonpharmaceut
prevent
measur
pilgrim
report
use
face
mask
pilgrimag
also
pilgrim
report
wash
hand
often
usual
use
hand
gel
respect
pilgrimag
final
report
use
dispos
handkerchief
hajj
total
pilgrim
present
least
one
respiratori
symptom
stay
ksa
cough
rhiniti
frequent
symptom
affect
particip
half
pilgrim
report
expector
report
dri
cough
voic
failur
report
fever
ili
particip
antibiot
use
rti
report
pilgrim
one
pilgrim
hospit
ksa
regard
possibl
lrti
symptom
particip
report
product
cough
without
nasal
throat
symptom
addit
pilgrim
present
febril
dyspnoea
dyspnea
febril
product
cough
respect
total
pilgrim
respiratori
symptom
still
symptomat
return
mean
time
arriv
ksa
onset
symptom
day
rang
day
data
shown
ill
pilgrim
present
onset
respiratori
symptom
station
mecca
second
minor
wave
mina
figur
tabl
show
preval
carriag
respiratori
pathogen
accord
sampl
time
figur
show
dynam
preval
pathogen
studi
period
overal
sampl
test
posit
least
one
pathogen
aureu
pathogen
frequent
isol
sampl
test
posit
high
posit
rate
also
observ
h
influenza
k
pneumonia
hrv
catarrhali
sampl
posit
coronavirus
pneumonia
sampl
test
posit
influenza
virus
case
posit
hpiv
posit
sampl
proport
posit
one
pathogen
total
sampl
posit
two
pathogen
three
pathogen
four
pathogen
five
pathogen
data
shown
pretravel
sampl
viru
carriag
low
particip
test
posit
hrv
hcov
bacteri
carriag
higher
notabl
h
influenza
catarrhali
aureu
k
pneumonia
pneumonia
carriag
rel
low
respect
dramat
increas
hrv
carriag
observ
day
pilgrimag
preval
time
higher
pretravel
hrv
carriag
decreas
progress
subsequ
sampl
still
eight
time
higher
posthajj
sampl
compar
prehajj
sevenfold
increas
hcov
carriag
observ
day
persist
day
pilgrimag
tend
slightli
decreas
posthajj
sampl
regard
bacteria
carriag
aureu
increas
factor
three
day
decreas
progress
subsequ
sampl
still
doubl
posthajj
sampl
compar
prehajj
interestingli
carriag
curv
hrv
aureu
strictli
parallel
catarrhali
carriag
pretravel
day
sampl
increas
posthajj
sampl
k
pneumonia
carriag
increas
threefold
prehajj
day
sampl
slightli
increas
subsequ
sampl
pneumonia
carriag
increas
constantli
overtim
sevenfold
increas
posthajj
sampl
compar
prehajj
final
h
influenza
carriag
first
decreas
day
factor
increas
posthajj
sampl
carriag
rate
higher
prehajj
sampl
tabl
show
factor
independ
associ
carriag
respiratori
pathogen
swab
pilgrim
posit
associ
observ
male
carriag
hrv
pneumonia
chronic
respiratori
diseas
also
associ
pneumonia
carriag
final
use
dispos
handkerchief
associ
decreas
carriag
h
influenza
antibiot
intak
ten
day
sampl
posit
associ
hcov
k
pneumonia
carriag
regard
interact
pathogen
observ
hrv
carriag
aureu
carriag
mutual
posit
associ
appli
h
influenza
catarrhali
carriag
pilgrim
carri
pneumonia
like
also
carri
catarrhali
patient
dual
carriag
h
influenza
pneumonia
six
time
like
also
carri
pneumonia
contrast
catarrhali
carriag
associ
reduc
carriag
k
pneumonia
tabl
show
result
multivari
risk
factor
analysi
possibl
lrti
symptom
chronic
respiratori
diseas
associ
possibl
lrti
symptom
obes
associ
dyspnea
carriag
k
pneumonia
catarrhaliss
aureu
h
influenzaerhinoviru
combin
associ
fourfold
eightfold
increas
dyspnoea
preval
respect
final
catarrhaliss
aureu
dual
carriag
associ
fivefold
increas
preval
febril
dyspnea
tabl
despit
recommend
take
individu
prevent
measur
prevent
rti
infect
remain
common
among
hajj
pilgrim
overcrowd
event
thought
increas
risk
transmiss
infecti
diseas
interact
respiratori
pathogen
probabl
one
factor
contribut
toward
develop
rti
knowledg
studi
respiratori
microbiota
alter
among
pilgrim
hajj
conduct
result
occurr
rti
symptom
line
previou
result
obtain
regard
french
pilgrim
other
notabl
observ
rti
symptom
occur
soon
pilgrim
arriv
mecca
symptom
start
day
arriv
correspond
period
pilgrim
station
mecca
hotel
visit
grand
mosqu
daili
highli
crowd
condit
common
also
confirm
overal
increas
carriag
respiratori
virus
bacteria
seen
compar
pretravel
sampl
posthajj
sampl
previous
document
higher
acquisit
rate
observ
rhinoviru
ninefold
increas
compar
pretravel
posthajj
carriag
pneumonia
sevenfold
increas
increas
observ
pathogen
test
studi
uniqu
design
studi
sequenti
systemat
sampl
regular
interv
allow
better
understand
dynam
pathogen
carriag
pilgrimag
carriag
rate
bacteria
virus
studi
line
observ
recent
studi
conduct
french
pilgrim
pilgrim
nation
use
method
detect
acquisit
respiratori
virus
aureu
occur
soon
arriv
saudi
arabia
decreas
gradual
day
contrast
pneumonia
k
pneumonia
carriag
increas
progress
end
visit
h
influenza
catarrhali
carriag
increas
later
initi
clearanc
hypothes
brutal
acquisit
respiratori
virus
upon
arriv
initi
step
trigger
subsequ
chang
rel
abund
resid
bacteria
alreadi
present
nasopharynx
pilgrim
appar
simultan
virus
aureu
carriag
increas
initi
wave
respiratori
symptom
suggest
pathogen
associ
respons
rti
affect
pilgrim
soon
arriv
mecca
subsequ
increas
resid
bacteria
occur
second
half
pilgrim
stay
saudi
arabia
appear
contemporan
second
wave
respiratori
symptom
suggest
rti
bacteri
origin
regard
interact
respiratori
pathogen
observ
clear
pattern
posit
associ
carriag
aureu
rhinoviru
acquisit
curv
strictli
parallel
furthermor
independ
posit
mutual
associ
carriag
two
pathogen
evidenc
multivari
model
sever
studi
reveal
posit
interact
natur
experiment
rhinoviru
infect
aureu
nasal
carrier
studi
also
underlin
rhinoviru
infect
may
facilit
propag
aureu
staphylococc
carrier
environ
transmiss
bacterium
human
among
healthi
person
experiment
infect
rhinoviru
rel
abund
aureu
first
increas
return
baselin
level
rhinoviru
infect
clear
result
suggest
chang
composit
respiratori
microbiota
follow
rhinoviru
infect
may
play
role
develop
bacteri
superinfect
morgen
et
al
propos
sever
potenti
mechan
rhinoviru
may
increas
bacteri
infect
rhinoviru
infect
promot
proinflammatori
cytokin
ifn
product
mainli
activ
rhinoviru
infect
cell
adher
aureu
significantli
higher
compar
uninfect
cell
inflamm
due
rhinoviru
infect
also
increas
cellular
pattern
facilit
adhes
intern
aureu
within
host
cell
also
observ
parallel
increas
h
influenza
catarrhali
carriag
day
posthajj
sampl
independ
posit
mutual
associ
carriag
two
pathogen
evidenc
multivari
model
dual
carriag
h
influenza
catarrhali
strongli
associ
pneumonia
carriag
turn
associ
catarrhali
carriag
result
consist
sever
studi
conduct
among
children
upper
rti
studi
competit
interact
pneumonia
h
influenza
depend
neutrophil
complement
addit
carriag
catarrhali
might
alter
competit
balanc
h
influenza
pneumonia
cocolon
pneumonia
h
influenza
catarrhali
associ
increas
risk
otiti
media
document
use
vivo
model
mix
speci
biofilm
play
role
increas
persist
ear
diseas
propos
mechan
posit
associ
bacteri
speci
includ
interspeci
quorum
sens
passiv
antimicrobi
resist
observ
experiment
model
otiti
media
final
model
show
catarrhali
carriag
neg
associ
k
pneumonia
carriag
knowledg
previous
publish
addit
found
male
gender
independ
associ
increas
rhinoviru
pneumonia
carriag
explan
unexpect
observ
carriag
pneumonia
higher
among
pilgrim
chronic
respiratori
diseas
support
current
french
recommend
vaccin
ipd
propos
atrisk
pilgrim
one
recent
studi
pilgrim
vaccin
ipd
seven
time
less
like
harbour
pneumonia
hajj
compar
unvaccin
pilgrim
studi
use
dispos
handkerchief
associ
signific
decreas
h
influenza
carriag
nonpharmaceut
individu
prevent
measur
cough
etiquett
hand
hygien
use
face
mask
disinfect
gel
dispos
handkerchief
recommend
hajj
pilgrim
nevertheless
effect
measur
poorli
investig
avail
result
contradictori
appar
associ
antibiot
use
hcov
k
pneumonia
carriag
warrant
investig
better
explor
unexpect
observ
also
confirm
chronic
respiratori
diseas
risk
factor
lrti
also
evidenc
role
respiratori
bacteria
includ
k
pneumonia
catarrhaliss
aureu
associ
h
influenzaerhinoviru
associ
occurr
possibl
lrti
symptom
reinforc
need
antibiot
use
case
lrti
symptom
studi
limit
studi
conduct
among
french
pilgrim
rel
small
sampl
size
gener
pilgrim
qpcr
use
detect
respiratori
pathogen
distinguish
dead
live
microorgan
small
number
respiratori
pathogen
investig
respiratori
bacteria
serotyp
investig
influenza
virus
includ
model
due
low
carriag
rate
addit
recruit
control
group
individu
particip
hajj
studi
address
interact
respiratori
pathogen
gener
french
adult
popul
could
interest
nevertheless
studi
first
studi
dynam
interact
respiratori
pathogen
frequent
isol
among
hajj
pilgrim
data
suggest
rti
hajj
result
complex
interact
number
respiratori
virus
bacteria
studi
aim
studi
respiratori
microbiota
tool
allow
identif
larger
number
pathogen
necessari
better
elucid
ecolog
chang
potenti
role
occurr
respiratori
symptom
